Search - tctmd.com

Displaying 61 - 80 of 92

Sort: Relevancy | Date

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Ricardo Sanz-Ruiz

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Jay H Traverse

October 15, 2015

Presentation TCT 2015

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Douglas W. Losordo

October 15, 2015

$Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina$

Presentation TCT 2015

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Presenter: Greg L. Kaluza, Joachim Schofer, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

Cell Therapy for CHF

Presenter: Henricus J. Duckers, Bernard J. Gersh, Timothy D. Henry

October 14, 2015

Presentation TCT 2015

TCTMD Global PCI Mapping Project: Description and Goals

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Ivan C. Rokos

October 11, 2015

Presentation TCT 2015

Improving Door-in-Door-out in STEMI Transfer: The Last Frontier

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Christopher B. Granger

October 11, 2015

Presentation TCT 2015

Telemedicine and Artificial Intelligence to Optimize STEMI Outcomes: The Brazil Experience

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Roberto Botelho

October 11, 2015

Presentation TCT 2015

Is Deferred Stenting an Option? Rationale for the DEFER-STEMI Trial

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Colin Berry

October 11, 2015

Presentation TCT 2015

A Fresh Look at the Pharmacoinvasive Strategy

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Eric R. Bates

October 11, 2015

Presentation TCT 2015

What Is Optimal Prehospital Pharmacotherapy for STEMI in 2015?

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Duane S. Pinto

October 11, 2015

Presentation TCT 2015

New Insights From the Stent for Life Initiative

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Petr Kala

October 11, 2015

Presentation TCT 2015

Latest Insights From Mission Lifeline: False Activations, Use of Nonguideline-Directed Medical Therapies, and More

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Alice K. Jacobs

October 11, 2015

Presentation TCT 2015

Description of the Ideal STEMI Network, Prehospital Care Directives, and Emergency Room Processes: Lessons Learned Over the Last 20 Years

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Hadley K. Wilson

October 11, 2015

Presentation TCT 2015

Obtaining Informed Consent in Difficult Scenarios Case 1: Patient Presenting With STEMI

Presenter: David A. Cox, Thomas D. Stuckey, Timothy D. Henry

October 11, 2015

Presentation TCT 2014

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Presenter: Timothy Henry

September 16, 2014

Presentation TCT 2014

Cell Therapy to Reverse Remodel the Failing Heart: State of the Art

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Timothy D. Henry

September 15, 2014

Presentation TCT 2013

Cool and Cath: Critical Appraisal of the New Guidelines

Presenter: Timothy Henry

October 30, 2013

Advertisement

Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How?

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Cell Therapy for CHF

TCTMD Global PCI Mapping Project: Description and Goals

Improving Door-in-Door-out in STEMI Transfer: The Last Frontier

Telemedicine and Artificial Intelligence to Optimize STEMI Outcomes: The Brazil Experience

Is Deferred Stenting an Option? Rationale for the DEFER-STEMI Trial

A Fresh Look at the Pharmacoinvasive Strategy

What Is Optimal Prehospital Pharmacotherapy for STEMI in 2015?

New Insights From the Stent for Life Initiative

Latest Insights From Mission Lifeline: False Activations, Use of Nonguideline-Directed Medical Therapies, and More

Description of the Ideal STEMI Network, Prehospital Care Directives, and Emergency Room Processes: Lessons Learned Over the Last 20 Years

Obtaining Informed Consent in Difficult Scenarios Case 1: Patient Presenting With STEMI

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Cell Therapy to Reverse Remodel the Failing Heart: State of the Art

Cool and Cath: Critical Appraisal of the New Guidelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content